The Pharmacological Role of Phosphatases (Acid and Alkaline Phosphomonoesterases) in Snake Venoms related to Release of Purines - a Multitoxin

Basic and Clinical Pharmacology and Toxicology

Volumn 108, Issue 2, 2011, Pages 79-83

  Dhananjaya, Bhadrapura L ^a,b   D'Souza, Cletus J M ^a  

^a UNIVERSITY OF MYSORE   (India)

^b CENTRAL UNIVERSITY OF KERALA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ADENOSINE; ADENOSINE 3' PHOSPHATE; ADENOSINE A3 RECEPTOR; ADENOSINE PHOSPHATE; ALKALINE PHOSPHATASE; DEOXYRIBONUCLEASE; INOSINE; PURINE DERIVATIVE; RIBONUCLEASE; SNAKE VENOM;

BLOOD VESSEL PERMEABILITY; CELL DEATH; ENVENOMATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HEART ARREST; HUMAN; HYDROLYSIS; HYPERTENSION; IMMOBILIZATION; KIDNEY FAILURE; MAST CELL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

ACID PHOSPHATASE; ADENOSINE; ALKALINE PHOSPHATASE; ANIMALS; SNAKE VENOMS; SNAKES;

EID: 78651442122     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00630.x     Document Type: Review

References (57)

1. Bieber AL. Metal and nonprotein constituents in snake venoms. In: Lee CY (ed.). Snake Venoms, Handbook of Exp. Pharmacol.Springer-Verlag, Berlin. 1979; 295-306.
2. Aird SD. Ophidian envenomation strategies and the role of purines. Toxicon 2002;40:335-93.
3. Aird SD. Taxonomic distribution and quantitative analysis of free purine and pyrimidine nucleosides in snake venoms. Comp Biochem Physiol B Biochem Mol Biol 2005;140:109-26.
4. Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon 1991;29:1279-303.
5. Williams V, White J. Variation in the composition of the venom from a single specimen of Pseudonaja textilis (common brown snake) over one year. Toxicon 1992;30:202-6.
6. Mirtschin PJ, Shine R, Nias TJ, Dunstan NL, Hough BJ, Mirtschin M. Influences on venom yield in Australian tigersnakes (Notechis scutatus) and brownsnakes (Pseudonaja textilis: Elapidae, Serpentes). Toxicon 2002;40:1581-92.
7. Saravia P, Rojas E, Arce V, Guevara C, Lopez JC, Chaves E et al. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications. Rev Biol Trop 2002;50:337-46.
8. Shashidharamurthy R, Jagadeesha DK, Girish KS, Kemparaju K. Variations in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution. Mol Cell Biochem 2002;229:93-101.
9. Jorge da Silva N Jr, Aird SD. Prey specificity, comparative lethality and compositional differences of coral snake venoms. Comp Biochem Physiol C Toxicol Pharmacol 2001;128:425-56.
10. Urdaneta AH, Bolanos F, Gutierrez JM. Feeding behavior and venom toxicity of coral snake Micrurus nigrocinctus (Serpentes: Elapidae) on its natural prey in captivity. Comp Biochem Physiol C Toxicol Pharmacol 2004;138:485-92.
11. Pawlak J, Mackessy SP, Fry BG, Bhatia M, Mourier G, Fruchart-Gaillard C et al. Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with bird-specific activity. J Biol Chem 2006;281:29030-41.
12. Kochva EA. The origin of snakes and evolution of the venom apparatus. Toxicon 1987;25:65-106.
13. Fry BG. From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res 2005;1:403-20.
14. 2-A complex multifunctional puzzle. In: Kini RM (ed.). Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism. John Wiley and Sons, New York, 1997; 1-28.
15. Gutierrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000;82:841-50.
16. Rael ED. Venom Phosphatases and 5'Nucleotidase. In: Bailey GS (ed.). Enzymes from Snake VenomsAlaken Press, Ft. Collins, 1998; 405-22.
17. Lumsden NG, Fry BG, Ventura S, Kini RM, Hodgson WC. The in vitro and in vivo pharmacological activity of Boiga dendrophila (mangrove catsnake) venom. Auton Autacoid Pharmacol 2004;2:107-13.
18. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;5:413-92.
19. Burnstock G. Purinergic signalling--an overview. Novartis Found Symp 2006;276:26-48.
20. Sawynok J. Adenosine and ATP receptors. Handb Exp Pharmacol 2007;177:309-28.
21. Boffa MC, Boffa GA. Correlations between the enzymatic activities and the factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochim Biophys Acta 1974;35:275-90.
22. Ouyang C, Huang TF. Inhibition of platelet aggregation by 5'-nucleotidase purified from Trimeresurus gramineus snake venom. Toxicon 1983;2:491-501.
23. Ouyang C, Huang TF. Platelet aggregation inhibitor from Agkistrodon acutus snake venom. Toxicon 1986;2:1099-106.
24. Dhananjaya BL, Nataraju A, Rajesh R, Raghavendra Gowda CD, Sharath BK, Vishwanath BS et al. Anticoagulant effect of Naja naja venom 5'nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acid. Toxicon 2006;4:411-21.
25. Iwanaga S, Suzuki T. Enzymes in snake venom. In: Hornburg H (ed.). Snake venoms, Handbook of Exp. Pharmacol. Springer-Verlag, Berlin, 1979; 52: 61-158.
26. Uzawa SJ. Phosphatases. Biochem 1932;15:19.
27. Tu AT, Chua A. Acid and alkaline phosphomonoesterase activities in snake venoms. Comp Biochem Physiol 1966;17: 297-307.
28. Uwatoko-Setoguchi Y. Studies on sea snake venom. VI. Pharmacological properties of Laticauda semifasciata venom and purification of toxic components, acid phosphomonoesterase and Phospholipase A in the venom. Acta Med Univ Kagoshima 1970;12:73-96.
29. Sifford CA, Sifford DH, Johnson BD. Acid phosphatase and proteinase activities of selected crotalid venoms. SAAS Bull Biochem Biotechnol 1996;9:9-16.
30. Sulkowski E, Bjork W, Laskowski M Sr. A specific and nonspecific alkaline monophosphatase in the venom of Bothrops atrox and their occurrence in the purified venom phosphodiesterase. J Biol Chem 1963;238:2477-86.
31. Suzuki T, Iwanaga S. Studies on snake venom. IV. Purification of alkaline phosphatases in cobra venoms. J Pharm Soc Jpn 1958;78:368-75.
32. Suzuki T, Iwanaga S. Studies on snake venom. III. Purification of some enzymes in Japanese Mamushi venom (Agistrodon halys blomhoffii, Boie). J Pharm Soc Jap 1958;78:362-7.
33. Acosta A, Rael ED, Maddux NL, Lieb CS. Detection of alkaline phosphatase in venom by blotting methods. Toxicon 1994;32:227-31.
34. Hassan F, El-Hawary MF, El-Ghazawy A. Acid and alkaline phosphomonoesterases in Egyptian snake venoms. Z Ernahrungswiss 1981;20:44-54.
35. Francis B, Seebart C, Kaiser II. Citrate is an endogenous inhibitor of snake venom enzymes by metal-ion chelation. Toxicon 1992;30:1239-46.
36. Barboni E, Kemeny DM, Campos S, Vernon CA. The purification of acid phosphatase from honey bee venom (Apis mellifica). Toxicon 1987;25:1097-103.
37. Grunwald T, Bockisch B, Spillner E, Ring J, Bredehorst R, Ollert MW. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3). J Allergy Clin Immunol 2006;117:848-54.
38. Ownby CL, Bjarnason J, Tu AT. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. Am J Pathol 1978;93: 201-18.
39. Bernheimer AW, Rudy B. Interactions between membranes and cytolytic peptides. Biochim Biophys Acta 1986;864:123-41.
40. Nunez CE, Angulo Y, Lomonte B. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon 2001;39:1587-94.
41. Ma D, Armugam A, Jeyaseelan K. Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay. Biochem J 2002;366:35-43.
42. 2B subtype. Br J Pharmacol 1999;102:198.
43. 2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol 1997;499:135-40.
44. Seligmann C, Kupatt C, Becker BF, Zahler S, Beblo S. Adenosine endogenously released during early reperfusion mitigates postischemic myocardial dysfunction by inhibiting platelet adhesion. J Cardiovasc Pharmacol 1998;32:156-63.
45. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993;268:16887-90.
46. Olsson RA, Pearson JD. Cardiovascular purinoreceptors. Physiol Rev 1990;70:761-845.
47. Castrop H. Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine. Acta Physiol (Oxf) 2007;189:3-14.
48. Dunwiddie TV, Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1982;220:70-6.
49. Barraco RA, Coffin VL, Altman HJ, Phillips JW. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Res 1983;272:392-5.
50. Winsky L, Harvey JA. Retardation of associative learning in the rabbit by an adenosine analog as measured by classical conditioning of the nictitating membrane response. J Neurosci 1986;6: 2684-90.
51. Palmour RM, Lipowski CJ, Simon CK, Ervin FR. Adenosine analogs inhibit fighting in isolated male mice. Life Sci 1989;44:1293-301.
52. 2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 1991;259:286-94.
53. Jain N, Kemp N, Adeyeno O, Buchanan P, Stone TW. Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 1995;116:2127-33.
54. 3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur J Pharmacol 1997;333:1-7.
55. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998;347:1-11.
56. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 2000;105:361-7.
57. 1 receptors. Mol Pharmacol 1993;44:835-40.